Related Experiment Video
Updated: Aug 8, 2026

Caspase-3 Activity in the Rat Amygdala Measured by Spectrofluorometry After Myocardial Infarction
Published on: January 13, 2016
Caspase-3-dependent apoptosis in vascular smooth muscle cell by proteasome inhibition
Sun Cheun Kim1, Mun-Chul Rho, Hyun Sun Lee
1Drug & Toxicology Section, National Institute of Scientific Investigation Central District Office, Daejeon, Korea.
Abstract:
The effects of a number of substances on neointima formation following angioplasty have been investigated in animal models. It was suggested that delivering of proteasome inhibitor to the site of vascular injury would be a potential therapeutic approach in prevention of vascular restenosis. But the mechanisms underlying biologic activities of proteasome inhibition in vascular smooth muscle cells (VSMCs) are largely unknown. We have investigated effects of proteasome inhibition on VSMCs using proteasome inhibitor MG115. MG115 induced apoptotic death in VSMCs as determined by viability, morphology, and DNA fragmentation. Proteasome inhibition was accompanied by up-regulation of p53, p21, and p27. In contrast, there were no appreciable alterations in the levels of Bcl-2 and Bax. Proteasome inhibition was followed by activation of caspase-3 but not of -8. The induction of apoptosis was suppressed by treatment with a selective inhibitor of the caspase-3 family, z-DEVD-fmk but not by NG-monomethyl-L-arginine. These results indicate that proteasome inhibition induces apoptosis in VSMCs by activation of caspase-3.
Insights
Proteasome inhibition with MG115 induces programmed cell death (apoptosis) in vascular smooth muscle cells (VSMCs). This process involves caspase-3 activation, offering potential therapeutic strategies for vascular restenosis.
Area of Science:
- Molecular Biology
- Cardiovascular Research
- Cellular Biology
Background:
- Vascular restenosis after angioplasty is a significant clinical challenge.
- Proteasome inhibitors are being explored as a therapeutic strategy to prevent vascular restenosis.
- The precise mechanisms of proteasome inhibition in vascular smooth muscle cells (VSMCs) remain unclear.
Purpose of the Study:
- To investigate the effects of proteasome inhibition on VSMCs.
- To elucidate the molecular mechanisms underlying proteasome inhibitor-induced apoptosis in VSMCs.
Main Methods:
- VSMCs were treated with the proteasome inhibitor MG115.
- Cell viability, morphology, and DNA fragmentation were assessed to determine apoptosis.
- Protein levels of p53, p21, p27, Bcl-2, Bax, and caspase activity were analyzed.
Main Results:
- MG115 induced apoptotic death in VSMCs.
- Proteasome inhibition led to increased p53, p21, and p27 levels, but not Bcl-2 or Bax.
- Apoptosis was mediated by the activation of caspase-3, not caspase-8, and was inhibited by a caspase-3 specific inhibitor.
Conclusions:
- Proteasome inhibition triggers apoptosis in VSMCs.
- The observed apoptosis is dependent on the activation of caspase-3.
- These findings suggest proteasome inhibition as a potential therapeutic avenue for preventing vascular restenosis.
More Related Videos
06:14Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function
Published on: June 11, 2017
08:28Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
Related Concept Videos
Apoptosis
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Role of Matrix Metalloproteases in Degradation of ECM
A...
Cellular Injury V: Apoptosis and Autophagy